Over the past many years, the quantity of individuals referred for allogeneic hematopoietic mobile transplantation has dropped significantly,133 even so the technique needs to be suggested to younger/suit patients in whom BCR/BCL2 inhibitor cure fails, especially in Individuals with TP53Continual lymphocytic leukemia (CLL) can be a lymphoid maligna